Bilandzic Maree, Rainczuk Adam, Green Emma, Fairweather Nicole, Jobling Thomas W, Plebanski Magdalena, Stephens Andrew N
Hudson Institute of Medical Research, Clayton 3168, Australia.
Department of Molecular and Translational Sciences, Monash University, Clayton 3168, Australia.
Cancers (Basel). 2019 Aug 22;11(9):1228. doi: 10.3390/cancers11091228.
Epithelial ovarian cancer metastasis is driven by spheroids, which are heterogeneous cancer cell aggregates released from the primary tumour mass that passively disseminate throughout the peritoneal cavity to promote tumour spread, disease recurrence, and acquired chemoresistance. Despite their clinical importance, the molecular events that control spheroid attachment and invasion into underlying healthy tissues remain poorly understood. We examined a novel in vitro invasion model using imaging mass spectrometry to establish a "snapshot" of the spheroid/mesothelial interface. Amongst numerous adhesion-related proteins, we identified a sub-population of highly motile, invasive cells that expressed the basal epithelial marker KRT14 as an absolute determinant of invasive potential. The loss of KRT14 completely abrogated the invasive capacity, but had no impact on cell viability or proliferation, suggesting an invasion-specific role. Our data demonstrate KRT14 cells as an ovarian cancer "leader cell" phenotype underlying tumor invasion, and suggest their importance as a clinically relevant target in directed anti-tumour therapies.
上皮性卵巢癌转移由球体驱动,球体是从原发性肿瘤块释放的异质性癌细胞聚集体,它们被动地散布在整个腹腔中,以促进肿瘤扩散、疾病复发和获得性化疗耐药。尽管它们具有临床重要性,但控制球体附着和侵入下层健康组织的分子事件仍知之甚少。我们使用成像质谱检查了一种新型体外侵袭模型,以建立球体/间皮界面的“快照”。在众多与粘附相关的蛋白质中,我们鉴定出一群高迁移率、侵袭性细胞,它们表达基底上皮标志物KRT14作为侵袭潜能的绝对决定因素。KRT14的缺失完全消除了侵袭能力,但对细胞活力或增殖没有影响,表明其具有侵袭特异性作用。我们的数据证明KRT14细胞是肿瘤侵袭背后的卵巢癌“领导细胞”表型,并表明它们作为定向抗肿瘤治疗中临床相关靶点的重要性。